Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amedisys Inc
(NQ:
AMED
)
75.35
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 30, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
75.35
Bid (Size)
57.00 (1)
Ask (Size)
78.39 (1)
Prev. Close
75.35
Today's Range
75.35 - 75.35
52wk Range
69.36 - 131.32
Shares Outstanding
32,631,959
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amedisys's Return On Capital Employed Overview
May 10, 2023
Via
Benzinga
AMEDISYS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Amedisys, Inc. - AMED
May 04, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
YTD
-10.16%
-10.16%
1 Month
-5.95%
-5.95%
3 Month
-18.05%
-18.05%
6 Month
-14.77%
-14.77%
1 Year
-34.99%
-34.99%
More News
Read More
Analyst Expectations for Amedisys's Future
May 04, 2023
Via
Benzinga
Healthcare Giants Join Hands: Option Care Health Acquires Amedisys in a $3.6 Billion Stock Swap
May 04, 2023
Via
Benzinga
AMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Amedisys, Inc. Is Fair to Shareholders
May 03, 2023
From
Halper Sadeh LLC
Via
Business Wire
Recap: Amedisys Q1 Earnings
May 03, 2023
Via
Benzinga
Analyst Ratings for Amedisys
April 13, 2023
Via
Benzinga
What 10 Analyst Ratings Have To Say About Amedisys
March 13, 2023
Via
Benzinga
Preview: Amedisys's Earnings
February 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
April 21, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Where Amedisys Stands With Analysts
February 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Via
Benzinga
Amedisys Board of Directors Authorizes $100 Million Stock Repurchase Program
February 09, 2023
From
Amedisys, Inc.
Via
GlobeNewswire
Analyst Ratings for Amedisys
January 19, 2023
Via
Benzinga
Expert Ratings for Amedisys
October 27, 2022
Via
Benzinga
Meta Platforms To Rally 34%? Here Are 10 Other Analyst Forecasts For Thursday
January 05, 2023
Via
Benzinga
Amedisys Completes Home Health Joint Venture with the University of Arkansas for Medical Sciences
December 13, 2022
From
Amedisys, Inc.
Via
GlobeNewswire
Amedisys is Named One of the Most Responsible Companies of 2023 by Statista and Newsweek
December 08, 2022
From
Amedisys, Inc.
Via
GlobeNewswire
Amedisys Names Scott Ginn Acting Chief Operating Officer
November 22, 2022
From
Amedisys, Inc.
Via
GlobeNewswire
Amedisys Statement on CY 2023 Home Health Final Rule
November 01, 2022
From
Amedisys, Inc.
Via
GlobeNewswire
Mastercard To $428? Plus This Analyst Slashes PT On Intel
October 31, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
October 27, 2022
Via
Benzinga
Why Meta Platforms Shares Dipped Around 25%; Here Are 77 Biggest Movers From Yesterday
October 28, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 27, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.